Novavax, Inc. (NASDAQ: NVAX) Share Price and News

$8.09 $-0.36 (-4.3%) 31 March 2026 at 7:00:00 am AEDT

Novavax, Inc. Chart and Price Data

About Novavax

Last updated 31-03-2026, 07:00:00am AEDT
Current Price $8.09
Change $-0.36 (-4.3%)
Close Price $8.09
Open Price $8.41
Bid $8.12
Ask $8.20
Day Range $7.94 - $8.42
Year Range $5.01 - $11.97
Volume 4,602
Average Volume 5,152,696
Market Cap $1,318,152,200.00
Earnings Per Share $2.38

Novavax, Inc. (NASDAQ: NVAX)
Latest News

health care worker giving a woman a COVID 19 vaccine
International Stock News

With COVID-19 variant threats rising, why are vaccine stocks falling?

Stock markets moved slightly higher despite general worries.

Read more »

disappointed and sad woman
International Stock News

Why shares of Novavax crashed 37.7% in May

Delays frustrated investors.

Read more »

covid vaccine shares represented by numbers 2021 with the one displayed as syringe
International Stock News

3 things to expect from Novavax in 2021

This may be the year of revenue.

Read more »

coronavirus stocks represented by vaccine vials alongside piles of cash
International Stock News

3 coronavirus stocks poised to soar in 2021

They're risky but could deliver huge returns in the new year.

Read more »

CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
International Stock News

Coronavirus vaccine race: 7 key things you'll want to know

Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

Read more »

International Stock News

How to invest in coronavirus vaccine stocks

Just follow these three simple steps.

Read more »

Globe on keyboard with investment key, international shares
⏸️ International Shares

Here are the top 5 US shares ASX investors have been buying

Tesla Inc (TSLA), Microsoft Corporation (MSFT) and Apple Inc (AAPL) were amongst the US shares that ASX investors were trading…

Read more »

International Stock News

Everything you need to know about the coronavirus vaccine race

Here are your answers to the questions that matter the most about COVID-19 vaccines in development

Read more »

Profile

since

Note